Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
11/2012
11/14/2012CN102772586A Preparation with hangover alleviating and liver protection functions and preparation method thereof
11/14/2012CN102772580A Traditional Chinese medicine decoction for treating migraine and preparation method thereof
11/14/2012CN102772576A Use of Pu'er tea in nerve injury resistance
11/14/2012CN102772570A Health-care medicinal liquor capable of promoting longevity and preserving health
11/14/2012CN102772555A Golden flower detoxicatcating tablet
11/14/2012CN102772554A Traditional Chinese medicine compound for curing schizophrenia
11/14/2012CN102772552A Radix rehmanniae and cedar seed beverage
11/14/2012CN102772550A Yin-nourishing and heat-clearing tablets
11/14/2012CN102772537A Multifunctional special efficiency traditional Chinese medicine tincture for external use
11/14/2012CN102772518A Tablets (pills) for calming nerves
11/14/2012CN102772469A Medicine composition used for preventing or treating senile dementia
11/14/2012CN102772462A Method for extracting and separating total saponins of panax ginseng from american ginseng
11/14/2012CN102772461A Application of medicament composition in preparing drug for preventing or treating senile dementia
11/14/2012CN102772460A Plant headache tablets
11/14/2012CN102772459A In-situ gel for treating migraine and preparation method thereof
11/14/2012CN102772448A Lucid ganoderma triterpene extraction method
11/14/2012CN102772434A Application and preparation method of medicament and functional food for treating brain paralysis
11/14/2012CN102772431A Application of lumbricus lyophilized powder in preparing traditional Chinese medicine or functional food for preparing vascular dementia
11/14/2012CN102772419A Application of sarcococca vegans alkaline D
11/14/2012CN102772418A Application of pachysamine/pachysandrine G
11/14/2012CN102772412A Application of NSC23766 on preparing medicines for treating mental excitation drug addiction
11/14/2012CN102772408A (1S,5S)-3-(5,6-dichloropyridin-3-yl)-3,6-diazabicyclo[3.2.0]heptane benzenesulfonate
11/14/2012CN102772407A Pharmaceutical composition for promoting nerve damage restoration and application thereof
11/14/2012CN102772404A Compositions of (r)-pramipexole and methods of using the same
11/14/2012CN102772393A Application of isobavachalcone in treating nerve inflammatory diseases
11/14/2012CN102772390A Venlafaxine hydrochloride sustained release capsule and preparation method thereof
11/14/2012CN102772388A Method for preparing flupirtine maleate capsule
11/14/2012CN102772357A Implantable polymeric device for sustained release of dopamine agonist
11/14/2012CN102771861A Functional drink recipe for preventing three-high, fat and inner fire and manufacturing method of functional drink recipe for preventing three-high, fat and inner fire
11/14/2012CN102771791A Healthcare food and preparation method and application thereof
11/14/2012CN102771786A Propolis and lucid ganoderma soft capsule with health care function and preparation method of propolis and lucid ganoderma soft capsule
11/14/2012CN102771766A Tricholoma matsutake health-care product containing traditional Chinese medicine extractives and preparation method of tricholoma matsutake health-care product containing traditional Chinese medicine extractives
11/14/2012CN102771599A Ginkgo leaf tea beverage
11/14/2012CN102357230B Traditional Chinese medicine preparation for treating radiation encephalopathy
11/14/2012CN102273531B Radix hedysari and sealwort health preserving tea and health preserving capsule
11/14/2012CN102240380B Traditional Chinese medicine preparation for treating senile vascular dementia
11/14/2012CN102225164B Bag for treating amnesia and calming nerves and preparation method thereof
11/14/2012CN102218146B ShRNA (Short Hairpin Ribonucleic Acid) kit for treating animal model suffered from alzheimer disease
11/14/2012CN102153549B Gamma carboline compound as well as preparation method and application thereof
11/14/2012CN102151306B Active combined product extracted from leechee pulp, preparation method thereof and application thereof
11/14/2012CN102060912B Amyloid protein oligomer conformation type epitope polypeptide and application thereof
11/14/2012CN102060911B Polypeptide combined with various amyloid protein monomers simultaneously and application thereof
11/14/2012CN102015645B Piperidine and pyrrolidine compounds
11/14/2012CN102014905B Donepezil-containing patch preparation and packaging thereof
11/14/2012CN102000318B Pharmaceutical composition for treating facial paralysis and preparation method thereof
11/14/2012CN102000184B Method for extracting substances for relieving alcoholism from honey trees
11/14/2012CN101903021B Alpha-aminoamide derivatives useful in the treatment of psychiatric disorders
11/14/2012CN101874028B 2-aza-bicyclo[3.3.0]octane derivatives
11/14/2012CN101835748B Amino arylsulfonamide compounds and their use as 5-HT6 ligands field of invention
11/14/2012CN101778846B 1,2-diamido-ethylene derivatives as orexin antagonists
11/14/2012CN101759672B Salvianolic acid B in radix salviae miltiorrhizae
11/14/2012CN101735211B Applications of 2,3-dihydro[1,5] benzothiazepine compounds or salts thereof in preparation of GSK-3beta inhibitor
11/14/2012CN101361853B Medicine composition for preventing the birth defect and improving the memory
11/14/2012CN101361821B Medicine combination for treating diabetic peripheral neuropathy and preparation method thereof
11/14/2012CN101321730B Cyclopropyl amines as modulators of the histamine H3 receptor
11/14/2012CN101309909B 2-phenylethylamino derivatives as calcium and/or sodium channel modulators
11/14/2012CN101306040B Medicine composition for preventing the birth defect and improving the memory
11/14/2012CN101269014B Orally disintegrating tablet of risperidone and preparation method thereof
11/14/2012CN101232822B Composition for reducing the risc of ethanol metabolism and alcohol induced neuropathy
11/14/2012CN101088499B Dry asarol emulsion and its prepn and application
11/14/2012CN101068801B Arylsulfonylmethyl or arylsulfonamide substituted aromatic compounds suitable for treating disorders that respond to modulation of the dopamine D3 receptor
11/13/2012US8309796 Chimeric PUFA polyketide synthase systems and uses thereof
11/13/2012US8309610 Crystalline forms of (1RS,3RS,6RS)-6-dimethylaminomethyl-1-(3-methoxyphenyl)cyclohexane-1,3-diol hydrochloride
11/13/2012US8309609 Use of benzylideneaminoguanidines and hydroxyguanidines as melanocortin receptor ligands
11/13/2012US8309570 E.g., dextromethorphan hydrobromide, amantadine, memantine, remacemide or riluzole; treating pain resulting from injury, trauma, lesion or other disorders in the spinal cord or brain
11/13/2012US8309355 Methods of treating Parkinson's disease using viral vectors
11/13/2012US8309352 Human cord blood as a source of neural tissue repair of the brain and spinal cord
11/13/2012US8309122 Oxymorphone controlled release formulations
11/13/2012US8309108 Intranasal compositions
11/13/2012US8309088 Method of treating osteoarthritis with an antibody to NGF
11/13/2012CA2708043C Tosylate salt of trans-n-isobutyl-3-fluoro-3- [3-fluoro-4- (pyrrolidin-1-yl-methyl) -phenyl] cyclobut anecarboxamide
11/13/2012CA2680262C Substituted dihydro and tetrahydro oxazolopyrimidinones, preparation and use thereof
11/13/2012CA2511294C Methods of treating neurological conditions with hematopoietic growth factors
11/13/2012CA2435096C Yeast strains autonomously producing steroids
11/08/2012WO2012151343A1 Pentylenetetrazole derivatives
11/08/2012WO2012150829A2 Noble triazolopyridine derivative or pharmaceutically acceptable salts thereof, production method thereof, and pharmaceutical composition including same
11/08/2012WO2012150676A1 Synthetic peptide capable of inducing expression of type-2 tnf receptor and use thereof
11/08/2012WO2012150543A1 Macrocyclic lactones and use thereof
11/08/2012WO2012150495A1 Synthetic peptides and random copolymers for the treatment of autoimmune disorders
11/08/2012WO2012150412A1 Novel combination of 4-(3-[cis-hexahydrocyclopenta[c]pyrrol-2(1h)-yl]propoxy)benzamide and an acetylcholinesterase inhibitor, and pharmaceutical compositions containing same
11/08/2012WO2012150231A1 Novel benzofurane-piperidine compounds
11/08/2012WO2012149614A1 Novel treatment of pain
11/08/2012WO2012124888A3 Composition comprising the extract of herbal combination for preventing or treating diabetic peripheral neuropathy
11/08/2012WO2012124887A3 Composition comprising the extract of herbs for preventing or treating neurodegenerative disorders
11/08/2012WO2012119045A3 Compositions and uses thereof to ameliorate pain
11/08/2012WO2012080729A4 Casein kinase 1delta (ck1delta) inhibitors and their use in the treatment of neurodegenerative diseases such as tauopathies
11/08/2012WO2012078647A3 Chemical composition to detect and treat amyloid in a patient's brain and retina
11/08/2012WO2012017119A3 Non -viral vectors for gene therapy
11/08/2012WO2012001647A3 C10rf32 for the treatment of multiple sclerosis, rheumatoid arthritis and other autoimmune disorders
11/08/2012US20120283670 Percutaneous absorption preparation comprising anti-dementia drug
11/08/2012US20120283461 Pasteurisation process for microbial cells and microbial oil
11/08/2012US20120283335 Analogs of Propofol, Preparation Thereof and Use as Anesthetics
11/08/2012US20120283327 Pharmaceutical compositions and therapeutic applications of a hydrocortisone derivative designated as deina
11/08/2012US20120283323 Treating Learning Deficits with Inhibitors of HMG CoA Reductase
11/08/2012US20120283321 Use of gambierol for treating and/or preventing neurodegenerative diseases related to tau and beta-amyloid
11/08/2012US20120283317 Methods and Compositions for Regulating RNA Import into Mitochondria
11/08/2012US20120283305 Cysteine protease inhibitors
11/08/2012US20120283303 Use of n-aminoimidazole cytoprotective compounds for treating cell death and/or gsk-3 mediated diseases
11/08/2012US20120283298 Methods for treating memory impairment
11/08/2012US20120283297 Oxadiazole substituted indazole derivatives for use as sphingosine 1-phosphate 1 (s1p1) receptor agonists
1 ... 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 ... 1833